UCSF

ZINC95616599

Substance Information

In ZINC since Heavy atoms Benign functionality
January 13th, 2014 0 Yes

CAS Numbers: 63074-08-8 , 63590-64-7 , 70024-40-7 , [70024-40-7]

Other Names:

azosin

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine HCl 2H2O; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride dihydrate; Adecur; C19H25N5O4.2H2O.HCl; Deflox; Dysalfa; Flotrin

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine; Terazosin; Terazosine

6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine

6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride

63590-64-7; C07127; Terazosin; Terazosine

63590-64-7; D08569; Terazosabb (TN); Terazosin (INN)

63590-64-7; Prestwick_146; Terazosin hydrochloride

70024-40-7; D00610; Hytrin (TN); Terazosin hydrochloride (USAN); Terazosin hydrochloride hydrate (JAN)

A-45975

Abbott 45975

Abbott 45975;Terazosina [INN-Spanish];Terazosine;Terazosine [INN-French];Terazosinum [INN-Latin]

ABBOTT-45975

ABT-975

Blavin

BRD-A22256192-003-03-7

CPD000058309; SAM002589982; Terazosin

Flotrin

Flumarc

Fosfomic

Heitrin

Hytracin

Hytrin

Hytrin BPH

Hytrine

Hytrinex

INN); Terazosin HCl (FDA

INN); Terazosin Hydrochloride (FDA

Itrin

JAN

Magnurol

MFCD00072144

MFCD00467965

MFCD00941408

MY-208

N/A

Terazosin (BAN

Terazosin HCl

Terazosin HCl (Hytrin)

Terazosin HCl Dihydrate

Terazosin hydrochloride

Terazosin hydrochloride dihydrate

terazosin; terazosina; terazosine; terazosinum

Terazosina [INN-Spanish]

Terazosine

Terazosine [INN-French]

terazosinhydrochloride

Terazosinum [INN-Latin]

Trazosin HCl

Urodie

USAN

USAN)

USP

USP)

Vasocard

Vasomet

Vicard

Zayasel

[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](tetrahydrofuran-2-yl)methanone

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.50e+00 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Target Adrenergic Receptor Selleck Chemicals
Indications antihypertensive KeyOrganics Bioactives
Patent Database Links EP0845462; EP1364659; EP1479666; EP1649855; EP1669345; EP1671630; EP1717226; EP1728508; EP1785144; EP1862181; EP1894567; EP1967202; EP1988098; US2001020038; US2002061879; US2002115655; US2002143007; US2004147575; US2004254182; US2005014759; US2005065161 ChEBI
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : T-8046; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE TO WHITE WITH A YELLOW CAST POWDER NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: T-8046; SUPPLIER_COMMENTS: WHITE TO WHITE WITH A YELLOW CAST POWDER NIH Clinical Collection via PubChem

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.